Abbott Laboratories (ABT)
Exchange: New York Stock Exchange
Currency: USD
Price: 0.00 ()
Summary
| 52 Week range | 200d Moving Avg. | Beta |
| 0.00 – 0.00 | 0.00 | 0.00 |
| Dividend | Dividend Yield | Ex-Dividend date |
| 0.00 | 0.00% | 0000-00-00 |
| P/E Ratio | Latest EPS | DGR 3 years |
| 31.08 | 1.33 | 17.13% |
Overvalued
Low
N.A.
High
Slow
Dividend Growth
Fast
Profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
| Sector: | Industry: | |
| Health Technology | Medical Specialties | |
 |
Total ESG Score
32 – 61 percentile
Environment
4 – 5 percentile
Social
21 – 5 percentile
Governance
13 – 5 percentile
Controversy level
3
MSCI ESG-Rating
BB
see MSCI ESG rating explained
Peers
– Cardinal Health Inc. (CAH)
– AbbVie Inc. (ABBV)
– Becton Dickinson (BDX)
– Medtronic plc (MDT)
– Johnson & Johnson (JNJ)
– West Pharmaceutical Services, Inc (WST)
Dividend Safety Metrics
| Latest EPS | 1.33 | |
| Annual Payout | 0.00 | |
| Payout Ratio | 0.00% | |
| Dividend growth | 25 Years | |
| Dividend Score | 84 | |
| Dividend Coverage Ratio | 0.00 | |
| Altman-Z score | 3.81 | Safe Zone |
Estimated Future Total Return Metrics
| Total return last 5Y | 23.70% | |
| Dividend growth 5Y | 11.60% | |
| Current dividend yield | 0.00% | |
| Average dividend yield last 5Y | 1.49% | |
| Estimated EPS growth next 5Y | 12.80% | |
| Extra return due to over/under valuation | -100.00% | |
| Estimated future return 5Y (CAGR) | -85.70% |
Abbott Laboratories (ABT) Valuation
Abbott Laboratories current dividend yield of 0.00% is -100% below its 5-year average. The 5-year average dividend yield is 1.49% (see red-line in chart). This indicates the stock looks overvalued today.
Abbott Laboratories (ABT) Performance
The chart below displays the total price return(%) of Abbott Laboratories for different periods:
Abbott Laboratories (ABT) Total Return
The chart below displays the (CAGR) total return (%) including all dividends paid of Abbott Laboratories for different periods:
Dividend Scorecard
| Dividend Yield (TTM) | Annual Payout | Payout Ratio | Dividend growth |
| 0.00 | 0.00 | 0.00% | 25 Years |
Dividend Growth Summary
| 3 Year Growth Rate (CAGR) | 17.13% |
| 5 Year Growth Rate (CAGR) | 11.60% |
| 10 Year Growth Rate (CAGR) | 7.15% |
Dividend Growth Rates History
| Year | Payout Amount | Annual Payout Growth (YoY) |
|---|---|---|
| 2022 | 0.940 | -47.8% |
| 2021 | 1.800 | 25.0% |
| 2020 | 1.440 | 12.5% |
| 2019 | 1.280 | 14.3% |
| 2018 | 1.120 | 5.7% |
| 2017 | 1.060 | 1.9% |
| 2016 | 1.040 | 8.3% |
| 2015 | 0.960 | 9.1% |
| 2014 | 0.880 | 57.1% |
| 2013 | 0.560 | -41.9% |
| 2012 | 0.964 | 6.9% |
| 2011 | 0.902 | 9.3% |
| 2010 | 0.825 | 10.3% |
| 2009 | 0.748 | 11.0% |
| 2008 | 0.674 | 10.6% |
Abbott Laboratories (ABT) Dividend Payment History